Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

Shohei Eto, Yoko Nukui, Miyuki Tsumura, Yu Nakagama, Kenichi Kashimada, Yoko Mizoguchi, Takanori Utsumi, Maki Taniguchi, Fumiaki Sakura, Kosuke Noma, Yusuke Yoshida, Shinichiro Ohshimo, Shintaro Nagashima, Keisuke Okamoto, Akifumi Endo, Kohsuke Imai, Hirokazu Kanegane, Hidenori Ohnishi, Shintaro Hirata, Eiji Sugiyama, Nobuaki Shime, Masanori Ito, Hiroki Ohge, Yasutoshi Kido, Paul Bastard, Jean-Laurent Casanova, Osamu Ohara, Junko Tanaka, Tomohiro Morio, Satoshi Okada

Open source

DOI: 10.1007/s10875-022-01308-3
Published: 2022-06-29
Container: Journal of Clinical Immunology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10875-022-01308-3,
  title = {Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19},
  author = {Shohei Eto and Yoko Nukui and Miyuki Tsumura and Yu Nakagama and Kenichi Kashimada and Yoko Mizoguchi and Takanori Utsumi and Maki Taniguchi and Fumiaki Sakura and Kosuke Noma and Yusuke Yoshida and Shinichiro Ohshimo and Shintaro Nagashima and Keisuke Okamoto and Akifumi Endo and Kohsuke Imai and Hirokazu Kanegane and Hidenori Ohnishi and Shintaro Hirata and Eiji Sugiyama and Nobuaki Shime and Masanori Ito and Hiroki Ohge and Yasutoshi Kido and Paul Bastard and Jean-Laurent Casanova and Osamu Ohara and Junko Tanaka and Tomohiro Morio and Satoshi Okada},
  year = {2022},
  journal = {Journal of Clinical Immunology},
  doi = {10.1007/s10875-022-01308-3},
  url = {https://doi.org/10.1007/s10875-022-01308-3}
}

RIS

TY  - JOUR
TI  - Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
AU  - Shohei Eto
AU  - Yoko Nukui
AU  - Miyuki Tsumura
AU  - Yu Nakagama
AU  - Kenichi Kashimada
AU  - Yoko Mizoguchi
AU  - Takanori Utsumi
AU  - Maki Taniguchi
AU  - Fumiaki Sakura
AU  - Kosuke Noma
AU  - Yusuke Yoshida
AU  - Shinichiro Ohshimo
AU  - Shintaro Nagashima
AU  - Keisuke Okamoto
AU  - Akifumi Endo
AU  - Kohsuke Imai
AU  - Hirokazu Kanegane
AU  - Hidenori Ohnishi
AU  - Shintaro Hirata
AU  - Eiji Sugiyama
AU  - Nobuaki Shime
AU  - Masanori Ito
AU  - Hiroki Ohge
AU  - Yasutoshi Kido
AU  - Paul Bastard
AU  - Jean-Laurent Casanova
AU  - Osamu Ohara
AU  - Junko Tanaka
AU  - Tomohiro Morio
AU  - Satoshi Okada
PY  - 2022
JO  - Journal of Clinical Immunology
DO  - 10.1007/s10875-022-01308-3
UR  - https://doi.org/10.1007/s10875-022-01308-3
ER  -

APA

Eto, S., Nukui, Y., Tsumura, M., Nakagama, Y., Kashimada, K., Mizoguchi, Y., Utsumi, T., Taniguchi, M., Sakura, F., Noma, K., Yoshida, Y., Ohshimo, S., Nagashima, S., Okamoto, K., Endo, A., Imai, K., Kanegane, H., Ohnishi, H., Hirata, S., Sugiyama, E., Shime, N., Ito, M., Ohge, H., Kido, Y., Bastard, P., Casanova, J., Ohara, O., Tanaka, J., Morio, T., & Okada, S. (2022). Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-022-01308-3

Source records

crossref · retrieved 2026-09-26T00:13:20.851Z